Pharmaceutical

TT-01488 by TransThera Sciences (Nanjing) for Mantle Cell Lymphoma: Likelihood of Approval

TT-01488 is under clinical development by TransThera Sciences (Nanjing) and currently in Phase I for Mantle Cell Lymphoma.

May 17, 2024 - 04:00
TT-01488 is under clinical development by TransThera Sciences (Nanjing) and currently in Phase I for Mantle Cell Lymphoma.
Read the original article

Tags:

Previous Article

Influenza (quadrivalent) vaccine by Pfizer for Influenzavirus A Infections: Like...

Next Article

MRNA-1365 by Moderna for Human Metapneumovirus Infections: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Cigna, Humana in talks to merge into health insurance giant, per report

STAT+: Cigna, Humana in talks to merge into health insu...

Nov 29, 2023

Adcentrx raises funds to advance ADCs into clinical development

Adcentrx raises funds to advance ADCs into clinical dev...

Apr 26, 2023

Takeda wins EU approval for paediatric use of Takhzyro in HAE

Takeda wins EU approval for paediatric use of Takhzyro ...

Nov 20, 2023